Breast Cancer: Recurrent Genomic Alterations: Difference between revisions

[unchecked revision][unchecked revision]
Added some more links
No edit summary
Line 606: Line 606:
|fusion, amplification, sequence variants
|fusion, amplification, sequence variants
|ER+ metastatic tumors resistant to ER-targeted theapies, resistance to CDK4/6 inhibitors, resistance to HER2 targeted therapies
|ER+ metastatic tumors resistant to ER-targeted theapies, resistance to CDK4/6 inhibitors, resistance to HER2 targeted therapies
|[https://pubmed.ncbi.nlm.nih.gov/32723837/ 32723837]; 35005994; [https://pubmed.ncbi.nlm.nih.gov/37541273/ 37541273]; [https://pubmed.ncbi.nlm.nih.gov/37980453/ 37980453]
|[https://pubmed.ncbi.nlm.nih.gov/32723837/ 32723837]; [https://pubmed.ncbi.nlm.nih.gov/35005994/ 35005994]; [https://pubmed.ncbi.nlm.nih.gov/37541273/ 37541273]; [https://pubmed.ncbi.nlm.nih.gov/37980453/ 37980453]
|-
|-
|''FGFR3''
|''FGFR3''
Line 661: Line 661:
|2
|2
|Other/Complex
|Other/Complex
|602294
|[https://omim.org/entry/131320?search=gata3&highlight=gata3 131320]
|[https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=GATA3 GATA3]
|[https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=GATA3 GATA3]
|[https://www.cbioportal.org/results/oncoprint?cancer_study_list=acbc_mskcc_2015%2Cbreast_cptac_gdc%2Cbrca_hta9_htan_2022%2Cbrca_metabric%2Cbreast_msk_2025%2Cbreast_msk_2018%2Cbrca_pareja_msk_2020%2Cbrca_mskcc_2019%2Cbreast_alpelisib_2020%2Cbrca_smc_2018%2Cbrca_bccrc_xenograft_2014%2Cbfn_duke_nus_2015%2Cbrca_bccrc%2Cbrca_broad%2Cbrca_sanger%2Cbrca_tcga_pub2015%2Cbrca_tcga%2Cbrca_tcga_pub%2Cbrca_tcga_pan_can_atlas_2018%2Cbrca_tcga_gdc%2Cbrca_jup_msk_2020%2Cbrca_mapk_hp_msk_2021%2Cmbc_msk_2021%2Cbrca_aurora_2023%2Cbrca_dfci_2020%2Cbrca_igr_2015%2Cbreast_ink4_msk_2021%2Cilc_msk_2023%2Cbrca_cptac_2020%2Cbrca_mbcproject_wagle_2017%2Cbrca_mbcproject_2022%2Cbrca_fuscc_2020&Z_SCORE_THRESHOLD=2.0&RPPA_SCORE_THRESHOLD=2.0&profileFilter=mutations%2Cstructural_variants%2Ccna%2Cgistic&case_set_id=all&gene_list=GATA3&geneset_list=%20&tab_index=tab_visualize&Action=Submit&exclude_germline_mutations=true GATA3 breast]
|[https://www.cbioportal.org/results/oncoprint?cancer_study_list=acbc_mskcc_2015%2Cbreast_cptac_gdc%2Cbrca_hta9_htan_2022%2Cbrca_metabric%2Cbreast_msk_2025%2Cbreast_msk_2018%2Cbrca_pareja_msk_2020%2Cbrca_mskcc_2019%2Cbreast_alpelisib_2020%2Cbrca_smc_2018%2Cbrca_bccrc_xenograft_2014%2Cbfn_duke_nus_2015%2Cbrca_bccrc%2Cbrca_broad%2Cbrca_sanger%2Cbrca_tcga_pub2015%2Cbrca_tcga%2Cbrca_tcga_pub%2Cbrca_tcga_pan_can_atlas_2018%2Cbrca_tcga_gdc%2Cbrca_jup_msk_2020%2Cbrca_mapk_hp_msk_2021%2Cmbc_msk_2021%2Cbrca_aurora_2023%2Cbrca_dfci_2020%2Cbrca_igr_2015%2Cbreast_ink4_msk_2021%2Cilc_msk_2023%2Cbrca_cptac_2020%2Cbrca_mbcproject_wagle_2017%2Cbrca_mbcproject_2022%2Cbrca_fuscc_2020&Z_SCORE_THRESHOLD=2.0&RPPA_SCORE_THRESHOLD=2.0&profileFilter=mutations%2Cstructural_variants%2Ccna%2Cgistic&case_set_id=all&gene_list=GATA3&geneset_list=%20&tab_index=tab_visualize&Action=Submit&exclude_germline_mutations=true GATA3 breast]